Medical Properties Trust (MPT) Earnings Dates, Call Summary & Reports

Compare

6,177 Followers

Earnings Data

Report Date

Apr 23, 2026

Before Open (Confirmed)

Period Ending

2026 (Q1)

Consensus EPS Forecast

0.01

Last Year’s EPS

-0.2

Same Quarter Last Year

Analyst Consensus

Moderate Buy

Based on 3 Analysts Ratings

Earnings Call Summary

Q4 2025

Earnings Call Date:Feb 19, 2026|

% Change Since:

Earnings Call Sentiment|Positive

The call conveyed multiple operational and financial positives — meaningful year-over-year EBITDARM gains across core segments (general acute and rehab), strategic lease restructurings (Vibra), selective accretive acquisitions, progress on Prospect recoveries, and clear targets for cash rent and rent ramp-through 2026. Offsetting these positives are isolated but material challenges: behavioral health softness (U.K. funding and U.S. labor pressures), lingering Prospect-related impairments and remaining collections, HSA cash-collection shortfalls (with remediation tied to a Q2 EMR implementation), and several near-term debt maturities that require refinancing actions. Overall, management presented confidence in portfolio resilience and multiple tactical options to address capital needs.

Company Guidance

Management reiterated that 2026 is expected to be a year of stabilization and rising cash rents, with a target of exceeding $1.0 billion in annualized cash rent by year-end 2026 and recently-transitioned tenants expected to reach 100% contractual rent by that time; portfolio EBITDARM coverage rose to 2.6x, driven by a >$130 million YoY increase at general acute operators and a $50 million YoY increase at post‑acute operators (Ernest +15%, Vibra +28%, Median +8%), while Median in Germany posted its strongest quarter with >20% QoQ EBITDARM growth and 90% occupancy. Key transaction and cash metrics cited include a new 20‑year master lease with Vibra and an $18 million one‑time cash payment from Vibra, acquisitions of a California post‑acute facility for ~$32 million and a European post‑acute facility for EUR 23 million, sale of 6 smaller properties, a new 15‑year NOR lease expected to stabilize at $45 million annual cash rent in December 2026, ~$70 million of Prospect bankruptcy proceeds received in Q4 with ~$60 million remaining expected in 2026, and a Q4 normalized FFO of $0.18/sh ($0.58/sh full year) (benefiting ~$0.03–$0.04/sh from one‑time cash receipts) offset by ~ $34 million of impairments. On the balance sheet, management highlighted near‑term maturities (EUR 500 million unsecured notes due Oct at 0.99%, bank revolver and $200 million term loan maturing June 2027 after presumed extension, and $1.4 billion unsecured notes due Oct 2027), recent $2.5 billion secured note issuances and 10‑year German financing trading around mid‑5% levels, a $150 million repurchase authorization (used to buy back just under 1% of market cap to date, ~ $25 million repurchased this quarter), and selective $60 million of accretive property investments.

Improved Portfolio Coverage and Strong Operator Performance

Total portfolio EBITDARM coverage increased year-over-year to 2.6x. General acute operators delivered more than $130 million of incremental EBITDARM versus the same quarter last year.

Post-Acute Portfolio Momentum

Post-acute care operators reported a $50 million year-over-year EBITDARM increase, highlighted by Ernest Health (+15% EBITDARM), Vibra (+28% EBITDARM) and Median (reported +8% in one section and >20% in Germany in another), demonstrating strong rehab performance and higher occupancies (Median Germany occupancy ~90%).

Vibra Restructuring and Master Lease

Completed a Vibra restructuring and signed a new 20-year master lease; collected approximately $18 million one-time payment as part of the transaction. Management noted Vibra refinanced its debt and is a significantly stronger tenant post-transaction.

Selective Acquisitions with Attractive Economics

Acquired a high-performing post-acute facility in California for ~ $32 million (described as strong cap rate) and a European post-acute facility for EUR 23 million; invested roughly $60 million in two well-performing post-acute rehab facilities to add to master leases.

Lease Wins and Rent Ramp Expectations

Entered a 15-year lease with NOR Health Systems expected to reach stabilized annual cash rent of $45 million by December 2026; management expects recently transitioned tenants to reach 100% contractual rent by end of 2026 and targets over $1 billion in annualized cash rent by year-end 2026.

Normalized FFO and One-Time Cash Benefits

Reported normalized FFO of $0.18 per share for Q4 and $0.58 per share for full year 2025. Management noted normalized FFO was approximately $0.03–$0.04 higher in the quarter due to cash receipts including Vibra restructuring and a $4 million HSA payment.

Cash Proceeds from Prospect Process

Received approximately $70 million of net proceeds from the Prospect bankruptcy in the quarter, with an expected remaining collection of ~$60 million in 2026 as the process concludes.

Balance Sheet Actions and Capital Markets Execution

Announced a $150 million share repurchase authorization and repurchased just under 1% of market cap by year-end; secured financing market access noted (prior secured notes trading at premiums implying ~5% rates), and management articulated multiple refinancing/deleveraging options for upcoming maturities.

Operational Wins — Refinancing and Partnerships

Ernest Health delivered double-digit EBITDARM growth and refinanced its 2026 term loan and revolver in Q4 extending maturities to 2030 and compressing its rates. Swiss Medical Network reported solid hospital EBITDARM growth and announced a clinical collaboration with the Mayo Clinic.

Medical Properties Trust (MPT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MPT Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Apr 23, 2026	2026 (Q1)	0.01 / -	-0.2	―	―	―
Feb 19, 2026	2025 (Q4)	0.01 / 0.03	-0.69	104.35% (+0.72)	―
Oct 30, 2025	2025 (Q3)	0.01 / -0.13	-1.34	90.30% (+1.21)
Jul 31, 2025	2025 (Q2)	>-0.01 / -0.16	-0.54	70.37% (+0.38)
May 01, 2025	2025 (Q1)	0.01 / -0.20	-1.23	83.74% (+1.03)	―
Feb 27, 2025	2024 (Q4)	-0.06 / -0.69	-1.11	37.84% (+0.42)	―
Nov 07, 2024	2024 (Q3)	0.02 / -1.34	0.19	-805.26% (-1.53)	―
Aug 08, 2024	2024 (Q2)	0.04 / -0.54	-0.07	-671.43% (-0.47)	―
May 09, 2024	2024 (Q1)	0.09 / -1.23	0.05	-2560.00% (-1.28)	―
Feb 21, 2024	2023 (Q4)	0.15 / -1.11	-0.24	-362.50% (-0.87)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

MPT Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Feb 19, 2026	$5.37	$6.02	+12.10%
Oct 30, 2025	$4.78	$5.08	+6.38%
Jul 31, 2025	$3.99	$3.98	-0.25%
May 01, 2025	$5.24	$4.88	-6.89%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Medical Properties Trust (MPT) report earnings?

Medical Properties Trust (MPT) is schdueled to report earning on Apr 23, 2026, Before Open (Confirmed).

What is Medical Properties Trust (MPT) earnings time?

Medical Properties Trust (MPT) earnings time is at Apr 23, 2026, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is MPT EPS forecast?

MPT EPS forecast for the fiscal quarter 2026 (Q1) is 0.01.